Transgene Biotek Ltd — Quarterly Results & Earnings

₹1.98

-2.15%

Profit Growth YoY-457.14%Latest quarter

Sales Growth YoY-16.67%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5Y14.15%5 year compound

📋

Quarterly Performance

YoY Profit Growth-457.14%

🔴 Significant decline

YoY Sales Growth-16.67%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

-411.11%

EPS Growth 5Y

14.15%

Interest Coverage

Higher = safer debt servicing

-1.25

ROE

-6.56%

ROCE

-1.75%

💡

Growth Analysis

Transgene Biotek Ltd reported YoY profit growth of -457.14% and revenue growth of -16.67% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at N/A and profits at 14.15% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Transgene Biotek Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Healthcare Service Provider Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.